Galapagos and Celera Genomics Sign Gene Function Analysis Agreement

ROCKVILLE, M.D. and MECHELEN, Belgium, June 20, 2005
Galapagos today announced that it has entered into a services
agreement with Celera Genomics Group (NYSE:CRA), an Applera
Corporation business. Under the agreement, Galapagos' services
division Galadeno will provide technology and adenoviral reagents
enabling Celera to analyze gene function in human cells and validate
potential drug targets. Galadeno will receive payments related to
its services and technology.Under the terms of the agreement,
Galadeno will construct recombinant adenoviruses harboring genes
selected by Celera. These custom-made viruses will be used to
introduce the genes into various cell types to evaluate their
function within biological pathways.

"We are delighted that Celera has decided to take advantage of
Galapagos' adenoviral technology. This service agreement will allow
Celera to utilize Galapagos' technology platform to perform cellular
assays and target validation studies in a very beneficial way," says
Onno van de Stolpe, CEO of Galapagos. "Our adenoviral platforms have
proven to deliver functionally validated drug targets for our
partners, opening significant opportunities for continued
collaboration. We are pleased that Celera has joined the growing
number of companies that choose Galapagos technology to study gene
function in human cells."

About Celera Genomics and Applera Corporation Applera Corporation
consists of two operating groups. The Celera Genomics Group is
engaged principally in the discovery and development of targeted
therapeutics for cancer, autoimmune and inflammatory diseases.
Celera Genomics is leveraging its proteomic, bioinformatic, and
genomic capabilities to identify and validate drug targets, and to
discover and develop small molecule therapeutics. It is also seeking
to advance therapeutic antibody and selected small molecule drug
programs in collaboration with global technology and market leaders.
The Applied Biosystems Group (NYSE:ABI) serves the life science
industry and research community by developing and marketing
instrument-based systems, consumables, software, and services.
Customers use these tools to analyze nucleic acids (DNA and RNA),
small molecules, and proteins to make scientific discoveries,
develop new pharmaceuticals, and conduct standardized testing.
Applied Biosystems is headquartered in Foster City, CA, and reported
sales of $1.7 billion during fiscal 2004. Celera Diagnostics, a
50/50 joint venture between Applied Biosystems and Celera Genomics,
is focused on discovery, development, and commercialization of
diagnostic products. Information about Applera Corporation,
including reports and other information filed by the company with
the Securities and Exchange Commission, is available at
www.applera.com, or by telephoning +1.800.762.6923. Information
about Celera Genomics is available at www.celera.com.

About Galapagos

Galapagos is a publicly traded, genomics-based drug discovery
company (Euronext Brussels, GLPG; Euronext Amsterdam, GLPGA) that
has successfully discovered and validated novel targets in the bone
and joint diseases - osteoarthritis, osteoporosis and rheumatoid
arthritis, as well as in asthma and Alzheimer's disease. Proprietary
targets and compounds resulting from these programs are used for
Galapagos' internal drug discovery programs, combined with selected
out-licensing and partnering of projects during development.
Galadeno, Galapagos' services unit, provides reagents and functional
screens to leading pharmaceutical, biotech and nutraceutical
companies for rapid identification and validation of novel drug
targets. Galapagos currently employs 69 people, including 17 PhDs,
and occupies facilities in Mechelen, Belgium, and Leiden, The
Netherlands. Partners include Bayer, Boehringer Ingelheim, Celgene,
GlaxoSmithKline, Vertex and Wyeth.

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
http://www.arizonabiotech.com/index.php

http://www.arizonabiotech.com/
<a href="http://www.arizonabiotech.com/">Arizona Biotech</a>
http://groups.yahoo.com/group/biotech-news/
<a href="http://groups.yahoo.com/group/biotech-news/">Biotech News</a>
http://www.arizonaentrepreneurs.com/
<a href="http://www.arizonaentrepreneurs.com/">Arizona Entrepreneurs</a>
http://www.azhttp.com/
<a href="http://www.azhttp.com/">Arizona High Tech</a>

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech